[Pain analysis is vital in rheumatic diseases. Pain often causes much worry to patients].
The article consists of a synthesis of a rheumatic pain symposium held at the annual meeting of the Swedish Medical Association in 1996. Various aspects of pain in rheumatic diseases were discussed, such as physiological, neurohumoral and neurogenic mechanisms, sensory stimulation treatment, differentiation of mechanical and inflammatory pain, quality enhancement by improved co-operation between primary and tertiary care facilities, pharmacological treatment with (centrally and peripherally acting) opioids, selective cyclo-oxygenase inhibitors, and NMDA (N-methyl-D-aspartate) receptor antagonists. For patients with rheumatic disorders exacerbated by pain problems, as for other patients, a pain diagnosis is of fundamental importance. This can be achieved by analysis of the social, psychological, physiological and medical factors contributing to the cause and degree of pain and to pain behaviour, and of the extent to which the pain may be nociceptive (i.e., inflammatory, mechanical, or ischaemic in origin), neurogenic or idiopathic. Pain analysis should be followed by individualised treatment focused on the patient's most crucial problems, thus enhancing the prospect of optimal treatment outcome.
Nisell
R
R
Reumatologkliniken, Karolinska, Stockholm.
Arnér
S
S
Ekblom
A
A
Hansson
P
P
Lundeberg
T
T
Németh
G
G
Petersson
I
I
D000700:Analgesics / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000503:physiopathology* / Q000523:psychology; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D006801:Humans; D010146:Pain / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology / Q000523:psychology; D012216:Rheumatic Diseases / Q000503:physiopathology* / Q000523:psychology; D012720:Severity of Illness Index
D000700:Analgesics; D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors
Smärtanalys vital vid reumatiska sjukdomar. Smärtan oftast patientens största bekymmer.